Akebia Therapeutics reported $65.95M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Akebia Therapeutics AKBA:US USD 65.95M 32.21M
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 38.7B 2.18B
Ardelyx ARDX:US USD 26.54M 168K
Astellas Pharma 4503:JP JPY 288B 30.1B
AstraZeneca AZN:LN USD 29.3B 229M
Avrobio Inc AVRO:US USD 15.2M 101K
Bayer BAYN:GR EUR 44.79B 157M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Fresenius Medical Care FME:GR EUR 13.79B 127M
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Ironwood Pharmaceuticals IRWD:US USD 395.85M 399K
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Moderna Inc MRNA:US USD 1.15B 384M
Opko Health OPK:US USD 251.64M 12.28M
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M